Increased Frequency of Gastrointestinal Symptoms in Patients with Fibromyalgia and Associated Factors: A Comparative Study
Ömer Nuri Pamuk
Hasan Ümit
Orbay Harmandar
Author Affiliations
- From the Departments of Rheumatology, Gastroenterology, and Internal Medicine, Trakya University Medical Faculty, Edirne, Turkey.
- Ö.N. Pamuk, MD, Associate Professor in Rheumatology, Department of Rheumatology; H. Ümit, MD, Assistant Professor in Gastroenterology, Department of Internal Medicine; O. Harmandar, MD, Resident-in-Chief, Department of Internal Medicine, Trakya University Medical Faculty.
* Address correspondence to Dr. Ö.N. Pamuk, Trakya University Medical Faculty, Department of Rheumatology, Edirne, 22030, Turkey. E-mail: omernpamuk@yahoo.com.
Abstract
Objective
To determine the frequency and severity of gastrointestinal (GI) symptoms in patients with fibromyalgia (FM).
Methods
We included 152 women with FM (mean age 45.4 ± 12.2 yrs), 98 women with rheumatoid arthritis (RA; mean age 45.5 ± 12.3 yrs), and 60 healthy female controls (mean age 44 ± 11.3 yrs). All patients were questioned about the severity of their chronic widespread pain, symptoms of FM, symptoms of dyspepsia, using a visual analog scale (VAS), and anxiety-depression scale. Patients were asked self-reported (yes/no), symptom-based (= 2 criteria) constipation and severity of constipation questions, and about the severity of quality of life (QOL) disturbance secondary to dyspepsia and constipation.
Results
Patients with FM had higher symptom severities for belching, reflux, bloating, sour taste, and vomiting than patients with RA and controls (all p values < 0.01). Patients with FM had significantly more dyspepsia-related QOL disturbances than the other 2 groups (p < 0.01). FM and RA patients had more frequent self-reported constipation than controls (respectively, 42.1%, 48%, 21.7%; p < 0.01). The frequency of symptom-based constipation was significantly higher in the RA group (49%) than in FM (29.6%) and control groups (23.3%) (p < 0.01). Constipation-related QOL disturbance was significantly higher in patients with FM than in controls (p < 0.01).
Conclusion
In patients with FM, the severity scores of dyspepsia symptoms, constipation, and dyspepsia-related QOL disturbance were higher than in patients with RA and controls. The higher GI symptom severity in patients with FM might have negative effects on their QOL.
References
Published online before print June 30, 2009, doi: 10.3899/jrheum.090024 The Journal of Rheumatology August 1, 2009 vol. 36 no. 8 1720-1724
Jacob Teitelbaum, M.D. is one of the most frequently quoted post viral CFS, fibromyalgia, energy, sleep and pain medical authorities in the world. He is the author of 12 books including You Can Heal from Long Covid, the best-selling From Fatigued to Fantastic!, Pain Free 1-2-3, The Complete Guide to Beating Sugar Addiction, Real Cause Real Cure, The Fatigue and Fibromyalgia Solution, and the popular free Smart Phone app Cures A-Z. He is the lead author of eight research studies and three medical textbook chapters on effective treatment for fibromyalgia and chronic fatigue syndrome. Dr. Teitelbaum appears often as a guest on news and talk shows nationwide, including past appearances on Good Morning America, The Dr. Oz Show, Oprah & Friends, CNN, and FoxNewsHealth.
Websites: Vitality101.com | EndFatigue.com
Facebook Support Group: Recovering from Fibromyalgia, Chronic Fatigue, and Long COVID
Facebook Page | Instagram
